The coronavirus vaccine does work against the UK's more transmissible variant of the disease, but more work is needed the head of one of the teams behind it has said.
BioNTech chief executive Ugur Sahin said he was confident the Covid-19 vaccine co-developed by his company would be effective against a variant that has emerged in Britain.
Speaking on Bild TV he said the German company would investigate the mutation in the coming days but that he viewed the matter with “with a degree of soberness”.
Countries across the globe shut their borders to Britain on Monday due to fears about a highly infectious new coronavirus strain, causing travel chaos and raising the prospect of food shortages in the United Kingdom.
Read more on mirror.co.uk